Hendrikluesch

UF College of Pharmacy researchers identified two small molecules that inhibit precancerous cell progression in pancreatic cancer.

The research will focus on marine organisms with exceptional biosynthetic potential, employing genomic and chemical approaches.

Hendrik Luesch’s discovery and complete chemical and pharmacological characterization of a novel marine natural product that can potentially fight cancer has earned him a 2021 UF Innovation of the Year award.

Dr. Hendrik Luesch and a team of researchers have discovered a novel marine natural product that binds to a new site of tubulin, an important target for cancer drugs.

Researchers in the UF College of Pharmacy teamed with collaborators in Singapore to study a novel drug candidate with marine origins as a new method to prevent or treat vision loss.

A UF College of Pharmacy researcher team led by Dr. Hendrik Luesch recently developed a novel molecule based on marine cyanobacteria, Apra S10, to target pancreatic cancer cells.

Natural Product Reports is the Royal Society of Chemistry’s journal for publication of reviews in all areas of natural products chemistry, including biosynthesis, chemical biology, pharmacology and organic synthesis.

Luesch's marine drug discovery research is highlighted in the video supporting UF's $3 billion fundraising campaign.

The symposium featured nearly 130 participants and plenary speakers from the Dana-Farber Cancer Institute, Scripps Research Institute-Florida and National Cancer Institute.

Hendrik Luesch, Ph.D., a professor and chair of medicinal chemistry and the Debbie and Sylvia DeSantis Chair in Natural Products Drug Discovery and Development, received the Golden Medal Award for his presentation at the 2nd International Conference on Herbal and Traditional Medicine.